GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vicore Pharma Holding AB (OSTO:VICO) » Definitions » Pretax Margin %

Vicore Pharma Holding AB (OSTO:VICO) Pretax Margin % : -1,647.56% (As of Dec. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Vicore Pharma Holding AB Pretax Margin %?

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Vicore Pharma Holding AB's Pre-Tax Income for the three months ended in Dec. 2024 was kr-84.1 Mil. Vicore Pharma Holding AB's Revenue for the three months ended in Dec. 2024 was kr5.1 Mil. Therefore, Vicore Pharma Holding AB's pretax margin for the quarter that ended in Dec. 2024 was -1,647.56%.

The historical rank and industry rank for Vicore Pharma Holding AB's Pretax Margin % or its related term are showing as below:

OSTO:VICO' s Pretax Margin % Range Over the Past 10 Years
Min: -4267.91   Med: -780.75   Max: -154.45
Current: -154.46


OSTO:VICO's Pretax Margin % is ranked worse than
52.36% of 997 companies
in the Biotechnology industry
Industry Median: -129.77 vs OSTO:VICO: -154.46

Vicore Pharma Holding AB Pretax Margin % Historical Data

The historical data trend for Vicore Pharma Holding AB's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vicore Pharma Holding AB Pretax Margin % Chart

Vicore Pharma Holding AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Pretax Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -154.45

Vicore Pharma Holding AB Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 30.33 - - -1,647.56

Competitive Comparison of Vicore Pharma Holding AB's Pretax Margin %

For the Biotechnology subindustry, Vicore Pharma Holding AB's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vicore Pharma Holding AB's Pretax Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Vicore Pharma Holding AB's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Vicore Pharma Holding AB's Pretax Margin % falls into.


;
;

Vicore Pharma Holding AB Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Vicore Pharma Holding AB's Pretax Margin for the fiscal year that ended in Dec. 2024 is calculated as

Pretax Margin=Pre-Tax Income (A: Dec. 2024 )/Revenue (A: Dec. 2024 )
=-168.89/109.346
=-154.45 %

Vicore Pharma Holding AB's Pretax Margin for the quarter that ended in Dec. 2024 is calculated as

Pretax Margin=Pre-Tax Income (Q: Dec. 2024 )/Revenue (Q: Dec. 2024 )
=-84.075/5.103
=-1,647.56 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Vicore Pharma Holding AB  (OSTO:VICO) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.


Vicore Pharma Holding AB Pretax Margin % Related Terms

Thank you for viewing the detailed overview of Vicore Pharma Holding AB's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Vicore Pharma Holding AB Business Description

Traded in Other Exchanges
Address
Kornhamnstorg 53, Stockholm, SWE, 111 27
Vicore Pharma Holding AB is as a clinical-stage pharmaceutical company focused on severe lung diseases. The company is establishing a portfolio in respiratory diseases, including idiopathic pulmonary fibrosis (IPF). Its C21 is a small molecule angiotensin II type 2 receptor agonist (ATRAG) currently in phase 2a development for IPF. The company also has an investigational medical device in clinical development namely, Almee which is a digital therapeutic leveraging cognitive behavioral therapy created to address the psychological impact of living with pulmonary fibrosis.

Vicore Pharma Holding AB Headlines

No Headlines